title: Owner assessment of therapeutic interventions for canine atopic dermatitis: a long-term retrospective analysis.
abstract: BACKGROUND
  Canine atopic dermatitis is a frequent diagnosis in veterinary medicine; however, the long-term prognosis for canine atopic dermatitis has not been evaluated in a systematic fashion.
  
  
  OBJECTIVE
  To compare the relative efficacy of commonly used therapies for canine atopic dermatitis in two groups of dogs over 5 and 10 year time periods.
  
  
  METHODS
  Dogs were identified from the medical record database of a privately owned veterinary dermatology practice in the USA.
  
  
  METHODS
  Clients completed a four-part, 28-question, Internet-based survey. Surveys were included in the analysis if one entire section was completed. Each question was completed independently of the answers to other questions.
  
  
  RESULTS
  Several respondents failed to complete all questions. Some respondents answered similar questions with contradictory answers. Each question was analysed individually. A total of 136 owner surveys were completed, 39 from the 10 year and 97 from the 5 year study dogs. Eighty-five of 135 respondents indicated that their pet was receiving some form of medical therapy for atopic dermatitis at the time of the survey. Thirty of 90 respondents (33.3%) indicated that their dog improved during a dietary trial. Five dogs met the study's definition for clinical cure. All five of these dogs had been treated with allergen-specific immunotherapy.
  
  
  CONCLUSIONS
  This study revealed that clients believe antihistamines can be a useful part of multimodal therapy for canine atopic dermatitis. The results also demonstrated that a significant number of canines benefited from dietary modification. In addition, allergen-specific immunotherapy was the only treatment to induce true clinical remission of atopic dermatitis.
authors.affiliation: Animal Dermatology Clinic, 3901 East 82nd Street, Indianapolis, IN 46240, USA. ddell@adcmg.com
authors.forename: Darin L
authors.initials: DL
authors.lastname: Dell
authors.forename: Craig E
authors.initials: CE
authors.lastname: Griffin
authors.forename: Lori A
authors.initials: LA
authors.lastname: Thompson
authors.forename: Joel D
authors.initials: JD
authors.lastname: Griffies
mesh_terms: D000818:Animals; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D003258:Consumer Behavior; D003625:Data Collection; D003876:Dermatitis, Atopic / Q000188:drug therapy / Q000628:therapy* / Q000662:veterinary*; D003879:Dermatologic Agents / Q000627:therapeutic use; D004283:Dog Diseases / Q000628:therapy*; D004285:Dogs; D006801:Humans; D012189:Retrospective Studies; D016896:Treatment Outcome
chemical_list: D000893:Anti-Inflammatory Agents; D003879:Dermatologic Agents